Kidney stones usually originate in kidneys and most of the kidney stones can be treated without surgery. However, they can develop anywhere along with the urinary tract, which consists of some parts like kidneys, bladder, ureters, and urethra. This is most likely to occur in people between the ages of 20 and 50. The treatment is tailored according to the type or size of the stone. Kidney stones are hard gatherings of salt and minerals often made up of calcium or uric acid. the huge percent of stones pass by itself within 3 to 6 weeks. In this situation, the only treatment required is pain relief.
The Global Urinary Stones Treatment Devices market was valued at $ 1.4 bn in 2018 and is forecasted to grow at a strong 4.4% CAGR between 2018 and 2026, resulting in 2026 global sales of $ 1.98 bn. Market-driven by poor nutrition driving rise in kidney stones and technological advancements in the field of ureteroscopy. However, lack of awareness regarding the treatment of kidney stones in some regions is the component hindering the growth of the market. Moreover, ongoing R&D activities in the field of kidney stone management will offer lucrative open opportunities to the market.
Urinary Stones Treatment Devices Market depending on type, calcium oxalate segment is expected due to the rising incidences of the formation of calcium oxalate crystals. This is the most frequently occurring kidney stones in the body and real causes include diabetes and obesity. A few people have a huge amount of calcium in their urine, increasing their risk of calcium stones and also with normal amounts of calcium in the urine the calcium stones might form for other reasons. There is also a consistent admission of a high protein diet that may lead to the formation of calcium oxalate crystals in the body raising the interest for imaging consequently, essentially contributing to the industry growth.
The Global Urinary Stones Treatment Devices Market is segmented based on Diagnosis, Treatment Type, Stone Type, and Region
Based on the Diagnosis: Abdominal X-ray, Computed Tomography (CT) Scan, Intravenous Pyelography (IVP) Or Intravenous Urogram, Ultrasound, and Abdominal MRI
Based on the Treatment Type: Percutaneous Nephrolithotomy (PCNL), Ureteroscopy (URS), Extracorporeal Shock Wave Lithotripsy (ESWL) and Medications
Based on the Stone Type: Calcium Phosphate, Cystine, Struvite, Uric Acid, and Calcium Oxalate
Based on the Region: North America, Asia-Pacific, Europe, and LAMEA. Among that North America region is projected to witness high growth during the forecast period due to the US is rising prevalence of kidney stones in the country as well as expanding the adoption of minimally invasive surgical procedures. And also, huge awareness about the availability of various treatments amongst the U.S. population will increase the industry growth
The key players of the Global Urinary Stones Treatment Devices in Healthcare market include C. R. Bard, Inc., Bard Medical Division, Boston Scientific Corp, Conmed Corporation, Convergent Laser Technologies, Cook Endoscopy, Cook Urological, Direx Systems Corp., Dornier MedTech GmbH, EDAP TMS S.A., Elmed Electronics & Medical Industry & Trade Inc., ELMSTech Medical, Inc., EMS SA, Fujinon Inc Medical Div, Gyrus ACMI Inc, HealthTronics, Inc., Hobbs Medical Inc, KARL STORZ GmbH & Co. KG, Limmer Laser GmbH, Lumenis Ltd., Medi-Globe GmbH and Medispec LTD.
Report Description: The report covers an in-depth analysis of the Global Urinary Stones Treatment Devices Market. The report assesses the market products pipeline by Diagnosis (Abdominal X-ray, Computed Tomography (CT) Scan, Intravenous Pyelography (IVP) Or Intravenous Urogram, Ultrasound and Abdominal MRI), by treatment type (Percutaneous Nephrolithotomy (PCNL), Ureteroscopy (URS), Extracorporeal Shock Wave Lithotripsy (ESWL) and Medications), by type (Calcium Phosphate, Cystine, Struvite, Uric Acid and Calcium Oxalate). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in the Global Urinary Stones Treatment Devices Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.